We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for GNC Holdings (GNC) This Earnings Season?
Read MoreHide Full Article
GNC Holdings, Inc. (GNC - Free Report) is expected to report fourth-quarter 2017 results on Feb 15, before the opening bell.
Last quarter, the company posted a negative earnings surprise of 3%. Also, GNC Holdings’ trailing four-quarter average earnings miss is 16.5%.
Let’s take a look at GNC Holdings’ announcement of preliminary fourth-quarter results.
Per the announcement, GNC Holdings saw an increase in fourth-quarter same store sales for domestic company-owned stores (including GNC.com sales) of 5.7%. Also, adjusted diluted earnings per share (EPS) are expected in the range of 24-25 cents compared with 7 cents in the prior-year quarter. In the year-ago quarter, the EPS decline was led by a substantial fall in revenues.
Meanwhile, the Zacks Consensus Estimate for earnings is pegged at 24 cents, reflecting a 25% decline from last quarter. Further, the Zacks Consensus Estimate for revenues is pegged at $558 million, reflecting a 8.4% drop from the preceding quarter.
Other Factors at Play
Dull Prospects in the U.S. & Canada Segment
GNC Holdings' third-quarter 2017 revenues dropped 2.9% year over year. The lower sales at the U.S. & Canada and manufacturing/wholesale segments can be cited as main reasons for the disappointing performance. In the absence of any catalyst, we expect a similar trend in the fourth quarter of 2017.
The Zacks Consensus Estimate for revenues at the segment stands at $452 million, reflecting a 4.4% decline from the year-ago quarter.
China e-commerce to Drive International Segment
Revenues at the international segment increased a whopping 19.3% in the last quarter. Revenues from international franchisees rose impressively. Solid performance in the China e-commerce platform is likely to be the key catalyst. As a result, the Zacks Consensus Estimate for revenues at the segment is pegged at $44.2 million, reflecting growth of 11.3% from the year-earlier quarter.
However, GNC Holdings has a number of competitors in the market that include large international pharmacy chains, supermarket firms and big U.S.-based companies with global operations. We expect the company to slash prices in the face of stiff competition, which in turn, might hurt margins.
Other Developments
On the bright side, the performance of One New GNC is improving gradually. PRO Access, the company’s premium loyalty offering, has enrolled nearly 585,000 members since its launch in March 2017. Apart from this, management is working on product pricing and innovation. Meanwhile, new consumer enrolment under the myGNC Rewards Program and launch of GNC storefront on Amazon buoy optimism.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: The Earnings ESP for GNC Holdings is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings carries a Zacks Rank #3, which increases the predictive power of ESP. However, we also need to have a positive ESP to be confident of a positive earnings surprise.
Stocks to Consider
Here are a few medical stocks worth considering as they have the right combination of elements to post an earnings beat this quarter.
Myriad Genetics (MYGN - Free Report) has an Earnings ESP of +0.42% and a Zacks Rank #3.
Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.09% and a Zacks Rank #3.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
What's in Store for GNC Holdings (GNC) This Earnings Season?
GNC Holdings, Inc. (GNC - Free Report) is expected to report fourth-quarter 2017 results on Feb 15, before the opening bell.
Last quarter, the company posted a negative earnings surprise of 3%. Also, GNC Holdings’ trailing four-quarter average earnings miss is 16.5%.
Let’s take a look at GNC Holdings’ announcement of preliminary fourth-quarter results.
Per the announcement, GNC Holdings saw an increase in fourth-quarter same store sales for domestic company-owned stores (including GNC.com sales) of 5.7%. Also, adjusted diluted earnings per share (EPS) are expected in the range of 24-25 cents compared with 7 cents in the prior-year quarter. In the year-ago quarter, the EPS decline was led by a substantial fall in revenues.
GNC Holdings, Inc. Price and EPS Surprise
GNC Holdings, Inc. Price and EPS Surprise | GNC Holdings, Inc. Quote
Meanwhile, the Zacks Consensus Estimate for earnings is pegged at 24 cents, reflecting a 25% decline from last quarter. Further, the Zacks Consensus Estimate for revenues is pegged at $558 million, reflecting a 8.4% drop from the preceding quarter.
Other Factors at Play
Dull Prospects in the U.S. & Canada Segment
GNC Holdings' third-quarter 2017 revenues dropped 2.9% year over year. The lower sales at the U.S. & Canada and manufacturing/wholesale segments can be cited as main reasons for the disappointing performance. In the absence of any catalyst, we expect a similar trend in the fourth quarter of 2017.
The Zacks Consensus Estimate for revenues at the segment stands at $452 million, reflecting a 4.4% decline from the year-ago quarter.
China e-commerce to Drive International Segment
Revenues at the international segment increased a whopping 19.3% in the last quarter. Revenues from international franchisees rose impressively. Solid performance in the China e-commerce platform is likely to be the key catalyst. As a result, the Zacks Consensus Estimate for revenues at the segment is pegged at $44.2 million, reflecting growth of 11.3% from the year-earlier quarter.
However, GNC Holdings has a number of competitors in the market that include large international pharmacy chains, supermarket firms and big U.S.-based companies with global operations. We expect the company to slash prices in the face of stiff competition, which in turn, might hurt margins.
Other Developments
On the bright side, the performance of One New GNC is improving gradually. PRO Access, the company’s premium loyalty offering, has enrolled nearly 585,000 members since its launch in March 2017. Apart from this, management is working on product pricing and innovation. Meanwhile, new consumer enrolment under the myGNC Rewards Program and launch of GNC storefront on Amazon buoy optimism.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: The Earnings ESP for GNC Holdings is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings carries a Zacks Rank #3, which increases the predictive power of ESP. However, we also need to have a positive ESP to be confident of a positive earnings surprise.
Stocks to Consider
Here are a few medical stocks worth considering as they have the right combination of elements to post an earnings beat this quarter.
Bio-Rad Laboratories (BIO - Free Report) has an Earnings ESP of +4.45% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Myriad Genetics (MYGN - Free Report) has an Earnings ESP of +0.42% and a Zacks Rank #3.
Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.09% and a Zacks Rank #3.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>